Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy
[Display omitted] In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis o...
Gespeichert in:
Veröffentlicht in: | Pharmacological research 2016-12, Vol.114, p.128-143 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 143 |
---|---|
container_issue | |
container_start_page | 128 |
container_title | Pharmacological research |
container_volume | 114 |
creator | Cheng, Yu-Ting Yang, Chun-Chih Shyur, Lie-Fen |
description | [Display omitted]
In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis or recurrence after surgery/therapy, drug resistance, adverse side effects, and so on. Oxidative stress (OS) plays a critical role in chronic/acute inflammation, carcinogenesis, tumor progression, and tumor invasion/metastasis which is also attributed to the dynamic and complex properties and activities in the tumor microenvironment (TME). Re-educating or reprogramming tumor-associated stromal or immune cells in the TME provides an approach for restoring immune surveillance impaired by disease in cancer patients to increase overall survival and reduce drug resistance. Herbal medicines or plant-derived natural products have historically been a major source of anti-cancer drugs. Delving into the lore of herbal medicine may uncover new leads for anti-cancer drugs. Phytomedicines have been widely documented to directly or indirectly target multiple signaling pathways and networks in cancer cells. A combination of anti-cancer drugs and polypharmacological plant-derived extracts or compounds may offer a significant advantage in sensitizing the efficacy of monotherapy and overcoming drug-induced resistance in cancer patients. This review introduces several phytochemicals and phytoextracts derived from medicinal plants or dietary vegetables that have been studied for their efficacy in preclinical cancer models. We address the underlying modes of action of induction of OS and deregulation of TME-associated stromal cells, mediators and signaling pathways, and reference the related clinical investigations that look at the single or combination use of phytochemicals and phytoextracts to sensitize anti-cancer drug effects and/or overcome drug resistance. |
doi_str_mv | 10.1016/j.phrs.2016.10.022 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835683008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661816306570</els_id><sourcerecordid>1835683008</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-cc1cbd5c94824b5f06fd5a7d41606ddf222a3a8712ae35d276bca2f83e756ee23</originalsourceid><addsrcrecordid>eNp9kE1OwzAQhS0EoqVwARYoSzYptpM4jsQGVfxJRbCAJbJce0JdNXGxnYruOAQn5CQ4amHJap6e3jzNfAidEjwmmLCLxXg1d35Mo47GGFO6h4YEVywlhLP9XudZyhjhA3Tk_QJjXOUEH6IBLcsqzys-RK9P802wDWijTAvfn18PVndLGUz7ltgPo6NaQ-KDA-8T2eokzCEJXWNd0hjlLLRr42zbQBuSOppKtgpcn3JytTlGB7VcejjZzRF6ubl-ntyl08fb-8nVNFV5RUOqFFEzXagq5zSfFTVmtS5kqXPCMNO6ppTKTPKSUAlZoWnJZkrSmmdQFgyAZiN0vu1dOfvegQ-iMV7BcilbsJ0XhGcF4xnGPEbpNhqP995BLVbONNJtBMGixyoWoscqeqy9F7HGpbNdfzeLrP5WfjnGwOU2APHLtQEnvDIQUWjjQAWhrfmv_wd7kIyh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835683008</pqid></control><display><type>article</type><title>Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Cheng, Yu-Ting ; Yang, Chun-Chih ; Shyur, Lie-Fen</creator><creatorcontrib>Cheng, Yu-Ting ; Yang, Chun-Chih ; Shyur, Lie-Fen</creatorcontrib><description>[Display omitted]
In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis or recurrence after surgery/therapy, drug resistance, adverse side effects, and so on. Oxidative stress (OS) plays a critical role in chronic/acute inflammation, carcinogenesis, tumor progression, and tumor invasion/metastasis which is also attributed to the dynamic and complex properties and activities in the tumor microenvironment (TME). Re-educating or reprogramming tumor-associated stromal or immune cells in the TME provides an approach for restoring immune surveillance impaired by disease in cancer patients to increase overall survival and reduce drug resistance. Herbal medicines or plant-derived natural products have historically been a major source of anti-cancer drugs. Delving into the lore of herbal medicine may uncover new leads for anti-cancer drugs. Phytomedicines have been widely documented to directly or indirectly target multiple signaling pathways and networks in cancer cells. A combination of anti-cancer drugs and polypharmacological plant-derived extracts or compounds may offer a significant advantage in sensitizing the efficacy of monotherapy and overcoming drug-induced resistance in cancer patients. This review introduces several phytochemicals and phytoextracts derived from medicinal plants or dietary vegetables that have been studied for their efficacy in preclinical cancer models. We address the underlying modes of action of induction of OS and deregulation of TME-associated stromal cells, mediators and signaling pathways, and reference the related clinical investigations that look at the single or combination use of phytochemicals and phytoextracts to sensitize anti-cancer drug effects and/or overcome drug resistance.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2016.10.022</identifier><identifier>PMID: 27794498</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Antineoplastic Agents, Phytogenic - pharmacology ; Antineoplastic Agents, Phytogenic - therapeutic use ; Drug-induced resistance ; Humans ; Inflammation - drug therapy ; Inflammation - immunology ; Inflammation - metabolism ; Inflammation - pathology ; Neoplasms - drug therapy ; Neoplasms - immunology ; Neoplasms - metabolism ; Neoplasms - pathology ; Oxidative stress ; Oxidative Stress - drug effects ; Phytomedicines ; Polypharmacology ; Signal Transduction - drug effects ; Tumor microenvironment ; Tumor Microenvironment - drug effects</subject><ispartof>Pharmacological research, 2016-12, Vol.114, p.128-143</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-cc1cbd5c94824b5f06fd5a7d41606ddf222a3a8712ae35d276bca2f83e756ee23</citedby><cites>FETCH-LOGICAL-c492t-cc1cbd5c94824b5f06fd5a7d41606ddf222a3a8712ae35d276bca2f83e756ee23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1043661816306570$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27794498$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, Yu-Ting</creatorcontrib><creatorcontrib>Yang, Chun-Chih</creatorcontrib><creatorcontrib>Shyur, Lie-Fen</creatorcontrib><title>Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>[Display omitted]
In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis or recurrence after surgery/therapy, drug resistance, adverse side effects, and so on. Oxidative stress (OS) plays a critical role in chronic/acute inflammation, carcinogenesis, tumor progression, and tumor invasion/metastasis which is also attributed to the dynamic and complex properties and activities in the tumor microenvironment (TME). Re-educating or reprogramming tumor-associated stromal or immune cells in the TME provides an approach for restoring immune surveillance impaired by disease in cancer patients to increase overall survival and reduce drug resistance. Herbal medicines or plant-derived natural products have historically been a major source of anti-cancer drugs. Delving into the lore of herbal medicine may uncover new leads for anti-cancer drugs. Phytomedicines have been widely documented to directly or indirectly target multiple signaling pathways and networks in cancer cells. A combination of anti-cancer drugs and polypharmacological plant-derived extracts or compounds may offer a significant advantage in sensitizing the efficacy of monotherapy and overcoming drug-induced resistance in cancer patients. This review introduces several phytochemicals and phytoextracts derived from medicinal plants or dietary vegetables that have been studied for their efficacy in preclinical cancer models. We address the underlying modes of action of induction of OS and deregulation of TME-associated stromal cells, mediators and signaling pathways, and reference the related clinical investigations that look at the single or combination use of phytochemicals and phytoextracts to sensitize anti-cancer drug effects and/or overcome drug resistance.</description><subject>Animals</subject><subject>Antineoplastic Agents, Phytogenic - pharmacology</subject><subject>Antineoplastic Agents, Phytogenic - therapeutic use</subject><subject>Drug-induced resistance</subject><subject>Humans</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - immunology</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - pathology</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Phytomedicines</subject><subject>Polypharmacology</subject><subject>Signal Transduction - drug effects</subject><subject>Tumor microenvironment</subject><subject>Tumor Microenvironment - drug effects</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1OwzAQhS0EoqVwARYoSzYptpM4jsQGVfxJRbCAJbJce0JdNXGxnYruOAQn5CQ4amHJap6e3jzNfAidEjwmmLCLxXg1d35Mo47GGFO6h4YEVywlhLP9XudZyhjhA3Tk_QJjXOUEH6IBLcsqzys-RK9P802wDWijTAvfn18PVndLGUz7ltgPo6NaQ-KDA-8T2eokzCEJXWNd0hjlLLRr42zbQBuSOppKtgpcn3JytTlGB7VcejjZzRF6ubl-ntyl08fb-8nVNFV5RUOqFFEzXagq5zSfFTVmtS5kqXPCMNO6ppTKTPKSUAlZoWnJZkrSmmdQFgyAZiN0vu1dOfvegQ-iMV7BcilbsJ0XhGcF4xnGPEbpNhqP995BLVbONNJtBMGixyoWoscqeqy9F7HGpbNdfzeLrP5WfjnGwOU2APHLtQEnvDIQUWjjQAWhrfmv_wd7kIyh</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Cheng, Yu-Ting</creator><creator>Yang, Chun-Chih</creator><creator>Shyur, Lie-Fen</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201612</creationdate><title>Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy</title><author>Cheng, Yu-Ting ; Yang, Chun-Chih ; Shyur, Lie-Fen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-cc1cbd5c94824b5f06fd5a7d41606ddf222a3a8712ae35d276bca2f83e756ee23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antineoplastic Agents, Phytogenic - pharmacology</topic><topic>Antineoplastic Agents, Phytogenic - therapeutic use</topic><topic>Drug-induced resistance</topic><topic>Humans</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - immunology</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - pathology</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Phytomedicines</topic><topic>Polypharmacology</topic><topic>Signal Transduction - drug effects</topic><topic>Tumor microenvironment</topic><topic>Tumor Microenvironment - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Yu-Ting</creatorcontrib><creatorcontrib>Yang, Chun-Chih</creatorcontrib><creatorcontrib>Shyur, Lie-Fen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Yu-Ting</au><au>Yang, Chun-Chih</au><au>Shyur, Lie-Fen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2016-12</date><risdate>2016</risdate><volume>114</volume><spage>128</spage><epage>143</epage><pages>128-143</pages><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>[Display omitted]
In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis or recurrence after surgery/therapy, drug resistance, adverse side effects, and so on. Oxidative stress (OS) plays a critical role in chronic/acute inflammation, carcinogenesis, tumor progression, and tumor invasion/metastasis which is also attributed to the dynamic and complex properties and activities in the tumor microenvironment (TME). Re-educating or reprogramming tumor-associated stromal or immune cells in the TME provides an approach for restoring immune surveillance impaired by disease in cancer patients to increase overall survival and reduce drug resistance. Herbal medicines or plant-derived natural products have historically been a major source of anti-cancer drugs. Delving into the lore of herbal medicine may uncover new leads for anti-cancer drugs. Phytomedicines have been widely documented to directly or indirectly target multiple signaling pathways and networks in cancer cells. A combination of anti-cancer drugs and polypharmacological plant-derived extracts or compounds may offer a significant advantage in sensitizing the efficacy of monotherapy and overcoming drug-induced resistance in cancer patients. This review introduces several phytochemicals and phytoextracts derived from medicinal plants or dietary vegetables that have been studied for their efficacy in preclinical cancer models. We address the underlying modes of action of induction of OS and deregulation of TME-associated stromal cells, mediators and signaling pathways, and reference the related clinical investigations that look at the single or combination use of phytochemicals and phytoextracts to sensitize anti-cancer drug effects and/or overcome drug resistance.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27794498</pmid><doi>10.1016/j.phrs.2016.10.022</doi><tpages>16</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-6618 |
ispartof | Pharmacological research, 2016-12, Vol.114, p.128-143 |
issn | 1043-6618 1096-1186 |
language | eng |
recordid | cdi_proquest_miscellaneous_1835683008 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Antineoplastic Agents, Phytogenic - pharmacology Antineoplastic Agents, Phytogenic - therapeutic use Drug-induced resistance Humans Inflammation - drug therapy Inflammation - immunology Inflammation - metabolism Inflammation - pathology Neoplasms - drug therapy Neoplasms - immunology Neoplasms - metabolism Neoplasms - pathology Oxidative stress Oxidative Stress - drug effects Phytomedicines Polypharmacology Signal Transduction - drug effects Tumor microenvironment Tumor Microenvironment - drug effects |
title | Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T04%3A31%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phytomedicine%E2%80%94Modulating%20oxidative%20stress%20and%20the%20tumor%20microenvironment%20for%20cancer%20therapy&rft.jtitle=Pharmacological%20research&rft.au=Cheng,%20Yu-Ting&rft.date=2016-12&rft.volume=114&rft.spage=128&rft.epage=143&rft.pages=128-143&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2016.10.022&rft_dat=%3Cproquest_cross%3E1835683008%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835683008&rft_id=info:pmid/27794498&rft_els_id=S1043661816306570&rfr_iscdi=true |